teriflunomide
sanofi
['aubagio']
treatment with aubagio significantly reduces the risk that adults with ris will develop symptoms of ms, trial data show. #aan2023 #news 
We exist to bring you science, research and clinical news about MS. We are a free digital publication dedicated to the patient community.